Paragon 28 Past Earnings Performance

Past criteria checks 0/6

Paragon 28's earnings have been declining at an average annual rate of -52.1%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 18.5% per year.

Key information

-52.1%

Earnings growth rate

-49.0%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate18.5%
Return on equity-40.3%
Net Margin-22.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Paragon 28 makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:7GQ Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24245-5620128
30 Jun 24235-5519730
31 Mar 24225-5419131
31 Dec 23216-4818030
30 Sep 23207-7417529
30 Jun 23201-7317128
31 Mar 23192-6916526
31 Dec 22181-6715925
30 Sep 22173-3314923
30 Jun 22162-2913821
31 Mar 22156-2212718
31 Dec 21147-1411316
30 Sep 21140-510114
30 Jun 2113448912
31 Mar 2112147912
31 Dec 2011137311
31 Dec 1910637410

Quality Earnings: 7GQ is currently unprofitable.

Growing Profit Margin: 7GQ is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 7GQ is unprofitable, and losses have increased over the past 5 years at a rate of 52.1% per year.

Accelerating Growth: Unable to compare 7GQ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 7GQ is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: 7GQ has a negative Return on Equity (-40.27%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies